Fagron Compounding Services recalls bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 871
Recalled September 24, 2025 · FDA recall D-0646-2025 · Fagron Compounding Services
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
109,320 syringes
Sold at
USA nationwide.
Description
Lack of Assurance of Sterility
Product
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226
Manufacturer(s)
Fagron Compounding Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →